December 9, 2025
.avif)
In this webinar, host Naresh Sunkara sits down with Mana.bio’s CEO, Yogev Debbi, and scientific co-founder, Prof. Avi Schroeder, to explore how automation, advanced data analytics, and artificial intelligence are transforming the way modern therapeutics are designed and delivered. Together, they discuss the scientific and technological advances enabling researchers to develop nucleic acid therapeutics with greater speed, scalability, and predictability.
The conversation highlights the industry’s shift away from traditional trial-and-error experimentation toward data-driven, automated, and AI-guided development workflows. Yogev and Avi share insights into Mana.bio’s platform and explain how integrated design–build–test loops, high-throughput experimentation, and machine learning models are helping overcome key challenges in drug delivery - accelerating progress across RNA, DNA, and other emerging therapeutic modalities.
Link to podcast here